非裔特异性多基因风险评分在8q24局部祖先背景下的效能差异
本研究基于PRACTICAL联盟6253名非洲遗传 ancestry 男性的基因型数据,利用93个主成分分析8q24区域3个非洲特异性SNP的遗传变异,并以Cox比例风险框架评估PHS46+African效能随主成分的变化。
要点
- PHS46+African的效能随8q24局部祖先背景显著变化,校准因子范围为0.41至2.94。
- 该评分对部分非洲男性的获益可达其他人的7倍,解释相对风险从3.6%到9.9%不等。
- 需进一步研究提升多基因风险评分的临床效用,以改善非洲 ancestry 男性的健康结局。
核心结论
- PHS46+African的效能与8q24区域的主成分强相关,不同非洲 ancestry 男性间的获益存在显著差异。
- 需进一步研究以提升多基因风险评分的临床效用,改善非洲 ancestry 男性的健康结局。
研究设计与样本
- 研究基于PRACTICAL联盟6253名非洲遗传 ancestry 男性的基因型数据。
- 使用93个主成分估计跨越3个非洲特异性8q24 SNP窗口的遗传变异。
- 采用Cox比例风险框架识别与PHS46+African效能最强相关的主成分对,并制定校准因子。
主要发现
- 预测校准因子范围为0.41至2.94,提示PHS46+African对部分非洲男性的获益可达他人的7倍。
- PHS46+African的解释相对风险在低校准因子个体为3.6%,在高校准因子个体为9.9%。
- 通过将数据集与1000 Genomes交叉参照,发现大陆分组与校准分组之间存在显著关联。
临床怎么用
- 临床解读非洲 ancestry 男性的PHS46+African评分时,需考虑8q24局部祖先背景对效能的影响。
- 该评分在不同个体间的获益差异较大,不宜对所有非洲 ancestry 男性等同应用。
局限性
- 研究仅基于PRACTICAL联盟数据,需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We previously developed an African-ancestry-specific polygenic hazard score (PHS46+African) that substantially improved prostate cancer risk stratification in men with African ancestry. The model consists of 46 SNPs identified in Europeans and 3 SNPs from 8q24 shown to improve model performance in Africans. Herein, we used principal component (PC) analysis to uncover subpopulations of men with African ancestry for whom the utility of PHS46+African may differ. MATERIALS AND METHODS: Genotypic data were obtained from the PRACTICAL consortium for 6253 men with African genetic ancestry. Genetic variation in a window spanning 3 African-specific 8q24 SNPs was estimated using 93 PCs. A Cox proportional hazards framework was used to identify the pair of PCs most strongly associated with the performance of PHS46+African. A calibration factor (CF) was formulated using Cox coefficients to quantify the extent to which the performance of PHS46+African varies with PC. RESULTS: CF of PHS46+African was strongly associated with the first and twentieth PCs. Predicted CF ranged from 0.41 to 2.94, suggesting that PHS46+African may be up to 7 times more beneficial to some African men than others. The explained relative risk for PHS46+African varied from 3.6% to 9.9% for individuals with low and high CF values, respectively. By cross-referencing our data set with 1000 Genomes, we identified significant associations between continental and calibration groupings. CONCLUSION: We identified PCs within 8q24 that were strongly associated with the performance of PHS46+African. Further research to improve the clinical utility of polygenic risk scores (or models) is needed to improve health outcomes for men of African ancestry.
引用
- Karunamuni RA, Huynh-Le MP, Fan CC, et al. Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24. Prostate Cancer Prostatic Dis. 2021. PMID: 34127801. doi:10.1038/s41391-021-00403-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。